National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection
Open Access
- 22 February 2016
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 16 (8) , 2453-2462
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102981)
This publication has 25 references indexed in Scilit:
- Induction Immunosuppressive Therapy in the Elderly Kidney Transplant Recipient in the United StatesClinical Journal of the American Society of Nephrology, 2011
- Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?Kidney International, 2009
- Graft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid-Free Maintenance ImmunosuppressionAmerican Journal of Transplantation, 2008
- Variations in the Risk for Cerebrovascular Events after Kidney Transplant Compared with Experience on the Waiting List and after Graft FailureClinical Journal of the American Society of Nephrology, 2008
- Prospective Comparison of the Use of Sirolimus and Cyclosporine in Recipients of a Kidney From an Expanded Criteria DonorTransplantation, 2008
- Novel Methods for Tracking Long-Term Maintenance Immunosuppression RegimensClinical Journal of the American Society of Nephrology, 2008
- Infectious complications after kidney transplantation: a single‐center experienceTransplant Infectious Disease, 2007
- Agreement of Immunosuppression Regimens Described in Medicare Pharmacy Claims with the Organ Procurement and Transplantation Network SurveyJournal of the American Society of Nephrology, 2006
- Infectious complications after kidney transplantation: current epidemiology and associated risk factorsClinical Transplantation, 2006
- Incidence and Predictors of Myocardial Infarction after Kidney TransplantationJournal of the American Society of Nephrology, 2005